Data indicate that a state of equilibrium between cytotoxic CD8+ T cell function and tumor cell proliferation can be disrupted through administration of interferon (IFN) γ to tumors, leading to tumor rejection (Liang et al., 2013a, 2013b). This evidence concerns the gene CD8A and neoplasm.